Company news

Cannabis Bioscience International Holdings, Inc. news in 2024

Cannabis Bioscience International Holdings, Inc.'s news releases, calls and decks from 2024, newest first.

View company

CBIH Files Petition to Include Alexis Bortell as Witness in DEA Rescheduling Hearing

December 15, 2024

A Letter from the Desk of CBIH

December 8, 2024

Presenting on the Emerging Growth Conference 77 Day 2 on December 5th Register Now

December 3, 2024

CBIH Advocates for Cannabis Policy Reform at DEA Reclassification Hearing

December 1, 2024

CBIH Unveils the Future of Wellness with Revolutionary Anti-Aging Chip

November 24, 2024

CBIH Strengthens Clinical Research Team in Preparation for Launch of Next-Generation Cannabinoid Solutions

November 17, 2024

Cannabis Bioscience International Holdings Selected to Participate in DEA Hearing on Cannabis Rescheduling Docket No. 1362 and Hearing Docket No. 24-44

November 11, 2024

CBIH Welcomes Charles Tamburello to Its Board, Strengthening M&A Strategy

November 3, 2024

CBIH Pursues Regulatory Compliance and Market Growth with Essential Licensing Applications

July 14, 2024

CBIH Charts Path to Future Leadership in Cannabis Medicine

July 7, 2024

CBIH advances Cancer Care with Novel Cannabis Patents for Breast and Pancreatic Cancers

June 30, 2024

CBIH Announces Strategic Advancements Initiated by Recently Appointed Director, Setting a New Paradigm and Driving Visionary Change

June 25, 2024

Unleashing the Potential of Cannabis: Cannabis Bioscience International Holdings Reaches a Historic Valuation

June 16, 2024

CBIH and Vita Biotech Forge Alliance to Propel Clinical Studies Forward

June 4, 2024

CBIH Engages Prestigious Law Firm for its First Patent Applications

May 19, 2024

CBIH Welcomes New Treasurer and Director, Mr. John E. Jones

May 5, 2024

CBIH Commences Clinical Trials of Osteoarthritis Injection "Orthocann"

March 19, 2024

CBIH Announces the Retirement of One Billion Shares

March 5, 2024

Brian Cuban Joins Cannabis Bioscience International Holdings as an Advisory Board Member

February 25, 2024

Cannabis Bioscience International Holdings, Inc. Announces Engagement of Bull in Advantage as its Investor Relations Firm

February 19, 2024